| H20010276 | 枸橼酸铋雷尼替丁片 | Bismuth Citrate;ranitidine | Tablet | Chemical Drugs | Import Drug Application | 2001-11-19 | 葛兰素史克（中国）投资有限公 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2002-07-25 | view |
| JYHB1701456 | 注射用阿莫西林钠克拉维酸钾 | amoxicillin sodium;potassium clavulanate | Lyophilized | Chemical Drugs | Supplementary Application | 2017-11-17 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd;Beecham Group Plc | Filed | 2017-12-10 | view |
| JYHB0700936 | 沙美特罗替卡松气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2007-09-12 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2008-05-27 | view |
| JYHB2100014 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2021-02-01 | view |
| JXHL0900440 | GW685698/GW642444 | fluticasone furoate;vilanterol | Active ingredient | Chemical Drugs | Import Drug Application | 2010-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd | Certificate Issued | 2010-12-30 | view |
| JYHB1400719 | 阿莫西林克拉维酸钾干混悬剂 | amoxicillin;potassium clavulanate | Suspension | Chemical Drugs | Supplementary Application | 2014-06-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd | Certificate Issued | 2015-12-17 | view |
| JYHB1900197 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2019-03-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2019-09-10 | view |
| JYHB1301258 | 沙美特罗替卡松粉吸入剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2013-10-12 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2015-11-10 | view |
| JYHB1200732 | 那曲肝素钙注射液 | nadroparin calcium | Injection | Chemical Drugs | Supplementary Application | 2012-07-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2014-08-29 | view |
| JYHB1501772 | 沙美特罗替卡松粉吸入剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2015-12-17 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2018-08-14 | view |
| JYHB1700919 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2017-07-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline AG | Certificate Issued | 2017-11-28 | view |
| JYHB0500792 | 阿德福韦酯 | adefovir dipivoxil | Active ingredient | Chemical Drugs | Supplementary Application | 2005-12-06 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;PPG-Sipsy SAS;Gilead Sciences Inc | Certificate Completed-Pending Issued | 2006-05-12 | view |
| JYSB2000611 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-14 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | In Review | 2020-12-10 | view |
| JXSS0700056 | 吸附无细胞百日咳、白喉、破伤风和b型流感嗜血杆菌联合疫苗 | Diphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine | Other | Biological Products(6) | Import Drug Application | 2007-12-18 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2009-09-08 | view |
| JYHZ1800210 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | License Renew | 2018-07-26 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Certificate Issued | 2019-04-15 | view |
| JYHB2100121 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | In Review | 2021-02-05 | view |
| JYHB1300502 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2013-04-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | Certificate Issued | 2014-02-24 | view |
| JYHB1100793 | 异维A酸凝胶 | isotretinoin | Gel | Chemical Drugs | Supplementary Application | 2011-10-18 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline (Ireland) Ltd;Stiefel Laboratories (Ireland) Ltd | Certificate Issued | 2012-05-10 | view |
| JYHZ1500179 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2015-05-16 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline Inc;Patheon Inc | Certificate Issued | 2016-08-18 | view |
| JYSB1600224 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2016-11-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2017-11-01 | view |
